Consent Forms Forms Jurisdiction Meeting Dates On-Line Resources Policies and Procedures Review Fees Submission Information Translation
Forms

Application to the Board

For New Applications to OHREB, whether they are for full board or expedited review, you will need the following forms:

  • INSTRUCTION SHEET (.doc, .pdf)
  • OHREB Application (.doc, .pdf)
    • Additional Co-Investigators (.doc, .pdf)
  • Genetics Addendum (.doc, .pdf)
  • Departmental Impact (.doc, .pdf)
    • List of departmental contacts (.doc, .pdf)
  • Health Records (.pdf)
  • Nursing (.doc,.pdf)
  • Pathology and Laboratory Medicine Impact (.doc, .xls)
  • Radiation Safety & Health Physics Department
  • Diagnostic Imaging Impact
    • Diagnostic Imaging
        Research summary (.doc)
        Research summary submission notes (.doc, .pdf)
        Summary cover letter for ethics (.doc)
    • Nuclear Medicine
        Research summary (.doc)
        Research summary submission notes (.doc)
        Summary cover letter for ethics (.doc)
  • Pharmacy
    • Studies Fees Memo (.pdf)
    • TOH Pharmacy Trial Fees (.pdf)
    • Request for Pharmacy Services (.doc, .pdf)
  • Opthamology (Guidelines .pdf, Eye 56 .pdf)
 

Application for Chart Review

Applications for chart review are available for download here and are also available in hard copy in Health Records Service

Study Renewal

To renew your study on an annual basis, you will need to complete and submit the following form 60 days in advance of the approval expiry date. If you have completed research participant enrollment, but research participants remain on follow-up, this form should be completed. If recruitment is still ongoing, submit a copy of the last approved Patient Information Sheet and/or Consent Forms. If they are being revised, attach a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form. Please ensure the OHREB's contact phone number is correct. The number is 613-798-5555, extension 14902.

IT IS THE INVESTIGATOR’S RESPONSIBILITY TO ENSURE THAT STUDY APPROVAL DOES NOT LAPSE. PATIENT RECRUITMENT CANNOT CONTINUE IF STUDY APPROVAL LAPSES

Study Termination

If your study is complete, you need to inform us by submitting the following form. Please do not complete this form if patients remain on follow-up (see Annual Renewal Form).

Study Amendments

If there has been an amendment to your study, please complete the following form. Be sure to include the appropriate revised documents. If there are changes required to the Patient Information and Consent Form because of the amendments, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.

Adverse Event Reporting

If there are any adverse events (SAEs) to report, please inform the OHREB by using the following form. If there are changes required to the Patient Information and Consent Form because of these adverse events, include a copy of the revised documents with all changes highlighted, and a clean final version of the revised document printed on original letterhead. Be sure to update the 'version' and 'date' on the revised form.

Jurisdiction

WHAT IS THE JURISDICTION OF THE RESEARCH ETHICS BOARD OF THE OTTAWA HOSPITAL?

The Ottawa Hospital Research Ethics Board is responsible for the protocols proposed by investigators at:

The Ottawa Hospital, Civic, General and Riverside campus;

The Ottawa Hospital Regional Cancer Centre;

University of Ottawa, Faculty of Medicine; and

University of Ottawa, Heart Institute

The administration of The Ottawa Hospital Research Ethics Board and the University of Ottawa Heart Institute Research Ethics Board (HREB) has now merged. Investigators that are associated with the University of Ottawa Heart Institute should continue to submit their protocols to the HREB for review. Where there is a question of overlap of patients, investigators should contact the Ottawa Hospital Research Ethics Board Research Office for clarification.